COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS

Ozdemir, B. HandanAyva, SebnemTerzi, AysenSade, L. ElifBasturk, BilkaySezgin, Atilla2020-10-202020-10-2020190934-0874http://hdl.handle.net/11727/4945enginfo:eu-repo/semantics/closedAccessCOMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTSconferenceObject32213213000491488703204